Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02323126
Title Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CHE | AUS

Facility Status City State Zip Country Details
University of Texas MD Anderson Cancer Center Thoractic Head/Neck Med.Onc(2) Houston Texas 77030 United States Details
Novartis Investigative Site Camperdown New South Wales 2050 Australia Details
Novartis Investigative Site Chermside Queensland 4032 Australia Details
Novartis Investigative Site La Tronche 38700 France Details
Novartis Investigative Site Koeln Nordrhein-Westfalen 50937 Germany Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Aviano PN 33081 Italy Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Malaga Andalucia 29010 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Alicante Comunidad Valenciana 03010 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Chur 7000 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field